Loading...

Adam Olshen, PhD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentEpidemiology & Biostatistics
Address550 16th. Street
San Francisco CA 94158
Phone415-514-9406
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wang SJ, Asthana S, van Zante A, Heaton CM, Phuchareon J, Stein L, Higuchi S, Kishimoto T, Chiu CY, Olshen A, McCormick F, Tetsu O. Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patient. Oral Oncol. 2017 Jun; 69:1-10. PMID: 28559012.
      View in: PubMed
    2. Williams KE, Lemieux GA, Hassis ME, Olshen A, Fisher SJ, Werb Z. Quantitative proteomic analyses of mammary organoids reveals distinct signatures after exposure to environmental chemicals. Proc Natl Acad Sci U S A. 2016 Mar 8; 113(10):E1343-51. PMID: 26903627.
      View in: PubMed
    3. Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen SR, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, Briones M, Carcamo B, Cooper T, Dahl GV, Emanuel PD, Fluchel MN, Goyal RK, Hayashi RJ, Hitzler J, Hugge C, Liu YL, Messinger YH, Mahoney DH, Monteleone P, Nemecek ER, Roehrs PA, Schore RJ, Stine KC, Takemoto CM, Toretsky JA, Costello JF, Olshen A, Stewart C, Li Y, Ma J, Gerbing RB, Alonzo TA, Getz G, Gruber TA, Golub TR, Stegmaier K, Loh ML. Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015 Dec 29; 48(1):101. PMID: 26711114.
      View in: PubMed
    4. Korkola JE, Heck S, Olshen A, Feldman DR, Reuter VE, Houldsworth J, Bosl GJ, Chaganti RS. Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach. PLoS One. 2015; 10(12):e0142846. PMID: 26624623.
      View in: PubMed
    5. Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen A, Schultz N, Taylor BS. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol. 2016 Feb; 34(2):155-63. PMID: 26619011.
      View in: PubMed
    6. Shain AH, Garrido M, Botton T, Talevich E, Yeh I, Sanborn JZ, Chung J, Wang NJ, Kakavand H, Mann GJ, Thompson JF, Wiesner T, Roy R, Olshen A, Gagnon A, Gray JW, Huh N, Hur JS, Busam KJ, Scolyer RA, Cho RJ, Murali R, Bastian BC. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet. 2015 Oct; 47(10):1194-9. PMID: 26343386; PMCID: PMC4589486 [Available on 04/01/16].
    7. Scheinin I, Sie D, Bengtsson H, van de Wiel MA, Olshen A, van Thuijl HF, van Essen HF, Eijk PP, Rustenburg F, Meijer GA, Reijneveld JC, Wesseling P, Pinkel D, Albertson DG, Ylstra B. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 2014 Dec; 24(12):2022-32. PMID: 25236618; PMCID: PMC4248318.
    8. Olshen A, Tang M, Cortes J, Gonen M, Hughes T, Branford S, Quintás-Cardama A, Michor F. Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib. Haematologica. 2014 Nov; 99(11):1701-9. PMID: 25216683; PMCID: PMC4222479.
    9. Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby PM, Queiroz EL, Nightingale K, Kerr AR, DeLacure MD, Veeramachaneni R, Olshen A, Albertson DG. Changes in abundance of oral microbiota associated with oral cancer. PLoS One. 2014; 9(6):e98741. PMID: 24887397; PMCID: PMC4041887.
    10. Nagarajan RP, Zhang B, Bell RJ, Johnson BE, Olshen A, Sundaram V, Li D, Graham AE, Diaz A, Fouse SD, Smirnov I, Song J, Paris PL, Wang T, Costello JF. Recurrent epimutations activate gene body promoters in primary glioblastoma. Genome Res. 2014 May; 24(5):761-74. PMID: 24709822; PMCID: PMC4009606.
    11. Stumpf CR, Moreno MV, Olshen A, Taylor BS, Ruggero D. The translational landscape of the mammalian cell cycle. Mol Cell. 2013 Nov 21; 52(4):574-82. PMID: 24120665; PMCID: PMC3959127.
    12. Olshen AB, Hsieh AC, Stumpf CR, Olshen A, Ruggero D, Taylor BS. Assessing gene-level translational control from ribosome profiling. Bioinformatics. 2013 Dec 1; 29(23):2995-3002. PMID: 24048356; PMCID: PMC3834798.
    13. Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ, Wullschleger S, Ostos LC, Lannon WA, Grotzinger C, Del Rio M, Lhermitte B, Olshen A, Wiedenmann B, Cantley LC, Gray JW, Hanahan D. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med. 2013 May; 19(5):619-25. PMID: 23584089; PMCID: PMC3774607.
    14. Mo Q, Wang S, Seshan VE, Olshen A, Schultz N, Sander C, Powers RS, Ladanyi M, Shen R. Pattern discovery and cancer gene identification in integrated cancer genomic data. Proc Natl Acad Sci U S A. 2013 Mar 12; 110(11):4245-50. PMID: 23431203; PMCID: PMC3600490.
    15. Nam JM, Ahmed KM, Costes S, Zhang H, Onodera Y, Olshen A, Hatanaka KC, Kinoshita R, Ishikawa M, Sabe H, Shirato H, Park CC. ß1-Integrin via NF-?B signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer. Breast Cancer Res. 2013; 15(4):R60. PMID: 23883667; PMCID: PMC3978561.
    16. Magbanua MJ, Sosa EV, Roy R, Eisenbud LE, Scott JH, Olshen A, Pinkel D, Rugo HS, Park JW. Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Res. 2013 Jan 1; 73(1):30-40. PMID: 23135909; PMCID: PMC4085329.
    17. Shen R, Mo Q, Schultz N, Seshan VE, Olshen A, Huse J, Ladanyi M, Sander C. Integrative subtype discovery in glioblastoma using iCluster. PLoS One. 2012; 7(4):e35236. PMID: 22539962; PMCID: PMC3335101.
    18. Bhattacharya A, Roy R, Snijders AM, Hamilton G, Paquette J, Tokuyasu T, Bengtsson H, Jordan RC, Olshen A, Pinkel D, Schmidt BL, Albertson DG. Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis. Clin Cancer Res. 2011 Nov 15; 17(22):7024-34. PMID: 22068658; PMCID: PMC3226754.
    19. Oricchio E, Nanjangud G, Wolfe AL, Schatz JH, Mavrakis KJ, Jiang M, Liu X, Bruno J, Heguy A, Olshen A, Socci ND, Teruya-Feldstein J, Weis-Garcia F, Tam W, Shaknovich R, Melnick A, Himanen JP, Chaganti RS, Wendel HG. The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell. 2011 Oct 28; 147(3):554-64. PMID: 22036564; PMCID: PMC3208379.
    20. Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, Dal Cin P, Antonescu CR, Singer S, Hameed M, Bovee JV, Hogendoorn PC, Socci N, Ladanyi M. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer. 2012 Feb; 51(2):127-39. PMID: 22034177; PMCID: PMC3235801.
    21. Olshen AB, Bengtsson H, Neuvial P, Spellman PT, Olshen A, Seshan VE. Parent-specific copy number in paired tumor-normal studies using circular binary segmentation. Bioinformatics. 2011 Aug 1; 27(15):2038-46. PMID: 21666266; PMCID: PMC3137217.
    22. Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L, Creaney J, Lake RA, Zakowski MF, Reva B, Sander C, Delsite R, Powell S, Zhou Q, Shen R, Olshen A, Rusch V, Ladanyi M. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet. 2011 Jul; 43(7):668-72. PMID: 21642991; PMCID: PMC4643098.
    23. Ostrovnaya I, Seshan VE, Olshen A, Begg CB. Clonality: an R package for testing clonal relatedness of two tumors from the same patient based on their genomic profiles. Bioinformatics. 2011 Jun 15; 27(12):1698-9. PMID: 21546399; PMCID: PMC3106202.
    24. Brevet M, Shimizu S, Bott MJ, Shukla N, Zhou Q, Olshen A, Rusch V, Ladanyi M. Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy. J Thorac Oncol. 2011 May; 6(5):864-74. PMID: 21774103.
      View in: PubMed
    25. Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, Cooc J, Weinkle J, Kim GE, Jakkula L, Feiler HS, Ko AH, Olshen A, Danenberg KL, Tempero MA, Spellman PT, Hanahan D, Gray JW. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011 Apr; 17(4):500-3. PMID: 21460848; PMCID: PMC3755490.
    26. Nabavizadeh N, Klifa C, Newitt D, Lu Y, Chen YY, Hsu H, Fisher C, Tokayasu T, Olshen A, Spellman P, Gray JW, Hylton N, Park CC. Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI. Integr Biol (Camb). 2011 Apr; 3(4):490-6. PMID: 21416100; PMCID: PMC3698966.
    27. Affer M, Dao S, Liu C, Olshen A, Mo Q, Viale A, Lambek CL, Marr TG, Clarkson BD. Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities. J Oncol. 2011; 2011:798592. PMID: 21436996; PMCID: PMC3062978.
    28. Bachleitner-Hofmann T, Sun MY, Chen CT, Liska D, Zeng Z, Viale A, Olshen A, Mittlboeck M, Christensen JG, Rosen N, Solit DB, Weiser MR. Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition. Clin Cancer Res. 2011 Jan 1; 17(1):122-33. PMID: 21208906; PMCID: PMC3263825.
    29. Moltzahn F, Olshen A, Baehner L, Peek A, Fong L, Stöppler H, Simko J, Hilton JF, Carroll P, Blelloch R. Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. Cancer Res. 2011 Jan 15; 71(2):550-60. PMID: 21098088; PMCID: PMC3022112.
    30. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, Olshen A, Ballinger T, Zhou X, Forsberg KJ, Gu J, Echipare L, O'Geen H, Lister R, Pelizzola M, Xi Y, Epstein CB, Bernstein BE, Hawkins RD, Ren B, Chung WY, Gu H, Bock C, Gnirke A, Zhang MQ, Haussler D, Ecker JR, Li W, Farnham PJ, Waterland RA, Meissner A, Marra MA, Hirst M, Milosavljevic A, Costello JF. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol. 2010 Oct; 28(10):1097-105. PMID: 20852635; PMCID: PMC2955169.
    31. Rose AE, Satagopan JM, Oddoux C, Zhou Q, Xu R, Olshen A, Yu JZ, Dash A, Jean-Gilles J, Reuter V, Gerald WL, Lee P, Osman I. Copy number and gene expression differences between African American and Caucasian American prostate cancer. J Transl Med. 2010; 8:70. PMID: 20649978; PMCID: PMC2913940.
    32. Ostrovnaya I, Olshen A, Seshan VE, Orlow I, Albertson DG, Begg CB. A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data. Stat Med. 2010 Jul 10; 29(15):1608-21. PMID: 20205270; PMCID: PMC3145177.
    33. Ostrovnaya I, Nanjangud G, Olshen A. A classification model for distinguishing copy number variants from cancer-related alterations. BMC Bioinformatics. 2010; 11:297. PMID: 20525196; PMCID: PMC2897829.
    34. Pothuri B, Leitao MM, Levine DA, Viale A, Olshen A, Arroyo C, Bogomolniy F, Olvera N, Lin O, Soslow RA, Robson ME, Offit K, Barakat RR, Boyd J. Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS One. 2010; 5(4):e10358. PMID: 20436685; PMCID: PMC2859950.
    35. Korkola JE, Houldsworth J, Feldman DR, Olshen A, Qin LX, Patil S, Reuter VE, Bosl GJ, Chaganti RS. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. J Clin Oncol. 2009 Nov 1; 27(31):5240-7. PMID: 19770384; PMCID: PMC3651602.
    36. Shen R, Olshen A, Ladanyi M. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics. 2009 Nov 15; 25(22):2906-12. PMID: 19759197; PMCID: PMC2800366.
    37. Filion C, Motoi T, Olshen A, Laé M, Emnett RJ, Gutmann DH, Perry A, Ladanyi M, Labelle Y. The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene. J Pathol. 2009 Jan; 217(1):83-93. PMID: 18855877; PMCID: PMC4429309.
    38. Houldsworth J, Petlakh M, Olshen A, Chaganti RS. Pathway activation in large B-cell non-Hodgkin lymphoma cell lines by doxorubicin reveals prognostic markers of in vivo response. Leuk Lymphoma. 2008 Nov; 49(11):2170-80. PMID: 19021061.
      View in: PubMed
    39. Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, Friedman E, Narod S, Olshen A, Gregersen P, Kosarin K, Olsh A, Bergeron J, Ellis NA, Klein RJ, Clark AG, Norton L, Dean M, Boyd J, Offit K. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A. 2008 Mar 18; 105(11):4340-5. PMID: 18326623; PMCID: PMC2393811.
    40. Olshen A, Gold B, Lohmueller KE, Struewing JP, Satagopan J, Stefanov SA, Eskin E, Kirchhoff T, Lautenberger JA, Klein RJ, Friedman E, Norton L, Ellis NA, Viale A, Lee CS, Borgen PI, Clark AG, Offit K, Boyd J. Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. BMC Genet. 2008; 9:14. PMID: 18251999; PMCID: PMC2259380.
    41. Zhou P, Comenzo RL, Olshen A, Bonvini E, Koenig S, Maslak PG, Fleisher M, Hoffman J, Jhanwar S, Young JW, Nimer SD, Boruchov AM. CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy. Blood. 2008 Apr 1; 111(7):3403-6. PMID: 18216299; PMCID: PMC2275009.
    42. Assimes TL, Olshen AB, Narasimhan B, Olshen A. Associations among multiple markers and complex disease: models, algorithms, and applications. Adv Genet. 2008; 60:437-64. PMID: 18358329.
      View in: PubMed
    43. Korkola JE, Heck S, Olshen A, Reuter VE, Bosl GJ, Houldsworth J, Chaganti RS. In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes Chromosomes Cancer. 2008 Jan; 47(1):43-55. PMID: 17943972.
      View in: PubMed
    44. Zhou P, Teruya-Feldstein J, Lu P, Fleisher M, Olshen A, Comenzo RL. Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan. Blood. 2008 Jan 15; 111(2):549-57. PMID: 17982021; PMCID: PMC2200859.
    45. Laé M, Ahn EH, Mercado GE, Chuai S, Edgar M, Pawel BR, Olshen A, Barr FG, Ladanyi M. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. J Pathol. 2007 Jun; 212(2):143-51. PMID: 17471488.
      View in: PubMed
    46. Venkatraman ES, Olshen A. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics. 2007 Mar 15; 23(6):657-63. PMID: 17234643.
      View in: PubMed
    47. Chadalavada RS, Korkola JE, Houldsworth J, Olshen A, Bosl GJ, Studer L, Chaganti RS. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells. 2007 Mar; 25(3):771-8. PMID: 17138961.
      View in: PubMed
    48. Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R, Dairkee S, Tokuyasu T, Ljung BM, Jain AN, McLennan J, Ziegler J, Chin K, Devries S, Feiler H, Gray JW, Waldman F, Pinkel D, Albertson DG. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer. 2006; 6:96. PMID: 16620391; PMCID: PMC1459181.
    49. López-Ríos F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen A, Ladanyi M. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res. 2006 Mar 15; 66(6):2970-9. PMID: 16540645.
      View in: PubMed
    50. Anderson SE, Nonaka D, Chuai S, Olshen A, Chi D, Sabbatini P, Soslow RA. p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas. Int J Gynecol Cancer. 2006 Mar-Apr; 16(2):849-53. PMID: 16681772.
      View in: PubMed
    51. Korkola JE, Houldsworth J, Chadalavada RS, Olshen A, Dobrzynski D, Reuter VE, Bosl GJ, Chaganti RS. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 2006 Jan 15; 66(2):820-7. PMID: 16424014.
      View in: PubMed
    52. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen A, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest. 2006 Jan; 116(1):271-84. PMID: 16395409; PMCID: PMC1323259.
    53. Ferguson SE, Olshen A, Levine DA, Viale A, Barakat RR, Boyd J. Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecol Oncol. 2006 May; 101(2):209-13. PMID: 16380157.
      View in: PubMed
    54. Chen W, Houldsworth J, Olshen A, Nanjangud G, Chaganti S, Venkatraman ES, Halaas J, Teruya-Feldstein J, Zelenetz AD, Chaganti RS. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood. 2006 Mar 15; 107(6):2477-85. PMID: 16317097; PMCID: PMC1895737.
    55. Leiser AL, Anderson SE, Nonaka D, Chuai S, Olshen A, Chi DS, Soslow RA. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecol Oncol. 2006 Apr; 101(1):86-91. PMID: 16289259.
      View in: PubMed
    56. Huang S, Li Y, Chen Y, Podsypanina K, Chamorro M, Olshen A, Desai KV, Tann A, Petersen D, Green JE, Varmus HE. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice. Genome Biol. 2005; 6(10):R84. PMID: 16207355; PMCID: PMC1257467.
    57. Moskowitz CH, Zelenetz AD, Kewalramani T, Hamlin P, Lessac-Chenen S, Houldsworth J, Olshen A, Chaganti R, Nimer S, Teruya-Feldstein J. Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL. Blood. 2005 Nov 15; 106(10):3383-5. PMID: 16091454.
      View in: PubMed
    58. Korkola JE, Houldsworth J, Dobrzynski D, Olshen A, Reuter VE, Bosl GJ, Chaganti RS. Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene. 2005 Jul 28; 24(32):5101-7. PMID: 15870693.
      View in: PubMed
    59. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen A, Gerald WL, Massagué J. Genes that mediate breast cancer metastasis to lung. Nature. 2005 Jul 28; 436(7050):518-24. PMID: 16049480; PMCID: PMC1283098.
    60. Ferguson SE, Olshen A, Viale A, Barakat RR, Boyd J. Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles. Clin Cancer Res. 2005 Mar 15; 11(6):2252-7. PMID: 15788674.
      View in: PubMed
    61. Chadalavada RS, Houldsworth J, Olshen A, Bosl GJ, Studer L, Chaganti RS. Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells. Funct Integr Genomics. 2005 Apr; 5(2):59-69. PMID: 15690164.
      View in: PubMed
    62. Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cordón-Cardo C, Olshen A, Gerald WL, Massagué J. Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol. 2005; 70:149-58. PMID: 16869748.
      View in: PubMed
    63. Olshen A, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004 Oct; 5(4):557-72. PMID: 15475419.
      View in: PubMed
    64. Leitao MM, Soslow RA, Nonaka D, Olshen A, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, Anderson S. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer. 2004 Sep 15; 101(6):1455-62. PMID: 15316901.
      View in: PubMed
    65. Yoon SS, Segal NH, Olshen A, Brennan MF, Singer S. Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma. Ann Oncol. 2004 Aug; 15(8):1261-6. PMID: 15277268.
      View in: PubMed
    66. Couëdel C, Mills KD, Barchi M, Shen L, Olshen A, Johnson RD, Nussenzweig A, Essers J, Kanaar R, Li GC, Alt FW, Jasin M. Collaboration of homologous recombination and nonhomologous end-joining factors for the survival and integrity of mice and cells. Genes Dev. 2004 Jun 1; 18(11):1293-304. PMID: 15175261; PMCID: PMC420355.
    67. Ferguson SE, Olshen A, Viale A, Awtrey CS, Barakat RR, Boyd J. Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma. Gynecol Oncol. 2004 Feb; 92(2):719-25. PMID: 14766275.
      View in: PubMed
    68. Houldsworth J, Olshen A, Cattoretti G, Donnelly GB, Teruya-Feldstein J, Qin J, Palanisamy N, Shen Y, Dyomina K, Petlakh M, Pan Q, Zelenetz AD, Dalla-Favera R, Chaganti RS. Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas. Blood. 2004 Mar 1; 103(5):1862-8. PMID: 14615382.
      View in: PubMed
    69. Westermark UK, Reyngold M, Olshen A, Baer R, Jasin M, Moynahan ME. BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks. Mol Cell Biol. 2003 Nov; 23(21):7926-36. PMID: 14560035; PMCID: PMC207645.
    70. Bastian BC, Olshen A, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003 Nov; 163(5):1765-70. PMID: 14578177; PMCID: PMC1892437.
    71. de Candia P, Solit DB, Giri D, Brogi E, Siegel PM, Olshen A, Muller WJ, Rosen N, Benezra R. Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors. Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12337-42. PMID: 14526102; PMCID: PMC218759.
    72. Lucito R, Healy J, Alexander J, Reiner A, Esposito D, Chi M, Rodgers L, Brady A, Sebat J, Troge J, West JA, Rostan S, Nguyen KC, Powers S, Ye KQ, Olshen A, Venkatraman E, Norton L, Wigler M. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res. 2003 Oct; 13(10):2291-305. PMID: 12975311; PMCID: PMC403708.
    73. Hedvat CV, Comenzo RL, Teruya-Feldstein J, Olshen A, Ely SA, Osman K, Zhang Y, Kalakonda N, Nimer SD. Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma. Br J Haematol. 2003 Sep; 122(5):728-44. PMID: 12930383.
      View in: PubMed
    74. Veltman JA, Fridlyand J, Pejavar S, Olshen A, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003 Jun 1; 63(11):2872-80. PMID: 12782593.
      View in: PubMed
    75. Solit DB, Basso AD, Olshen A, Scher HI, Rosen N. Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol. Cancer Res. 2003 May 1; 63(9):2139-44. PMID: 12727831.
      View in: PubMed
    76. Staack A, Kassis AP, Olshen A, Wang Y, Wu D, Carroll PR, Grossfeld GD, Cunha GR, Hayward SW. Quantitation of apoptotic activity following castration in human prostatic tissue in vivo. Prostate. 2003 Feb 15; 54(3):212-9. PMID: 12518326.
      View in: PubMed
    77. Olshen A, Jain AN. Deriving quantitative conclusions from microarray expression data. Bioinformatics. 2002 Jul; 18(7):961-70. PMID: 12117794.
      View in: PubMed
    78. Massion PP, Kuo WL, Stokoe D, Olshen A, Treseler PA, Chin K, Chen C, Polikoff D, Jain AN, Pinkel D, Albertson DG, Jablons DM, Gray JW. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res. 2002 Jul 1; 62(13):3636-40. PMID: 12097266.
      View in: PubMed
    79. Wilhelm M, Veltman JA, Olshen A, Jain AN, Moore DH, Presti JC, Kovacs G, Waldman FM. Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res. 2002 Feb 15; 62(4):957-60. PMID: 11861363.
      View in: PubMed
    80. Olivier M, Aggarwal A, Allen J, Almendras AA, Bajorek ES, Beasley EM, Brady SD, Bushard JM, Bustos VI, Chu A, Chung TR, De Witte A, Denys ME, Dominguez R, Fang NY, Foster BD, Freudenberg RW, Hadley D, Hamilton LR, Jeffrey TJ, Kelly L, Lazzeroni L, Levy MR, Lewis SC, Liu X, Lopez FJ, Louie B, Marquis JP, Martinez RA, Matsuura MK, Misherghi NS, Norton JA, Olshen A, Perkins SM, Perou AJ, Piercy C, Piercy M, Qin F, Reif T, Sheppard K, Shokoohi V, Smick GA, Sun WL, Stewart EA, Fernando J, Tran NM, Trejo T, Vo NT, Yan SC, Zierten DL, Zhao S, Sachidanandam R, Trask BJ, Myers RM, Cox DR. A high-resolution radiation hybrid map of the human genome draft sequence. Science. 2001 Feb 16; 291(5507):1298-302. PMID: 11181994.
      View in: PubMed
    81. Eary JF, Mankoff DA, Spence AM, Berger MS, Olshen A, Link JM, O'Sullivan F, Krohn KA. 2-[C-11]thymidine imaging of malignant brain tumors. Cancer Res. 1999 Feb 1; 59(3):615-21. PMID: 9973209.
      View in: PubMed
    82. Eubank WB, Mankoff DA, Schmiedl UP, Winter TC, Fisher ER, Olshen A, Graham MM, Eary JF. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy. AJR Am J Roentgenol. 1998 Oct; 171(4):1103-10. PMID: 9763005.
      View in: PubMed
    83. Olshen A, Wijsman EM. Pedigree analysis package vs. MIXD: fitting the mixed model on a large pedigree. Genet Epidemiol. 1996; 13(1):91-106. PMID: 8647381.
      View in: PubMed
    84. Thompson EA, Lin S, Olshen A, Wijsman EM. Monte Carlo analysis on a large pedigree. Genet Epidemiol. 1993; 10(6):677-82. PMID: 8314080.
      View in: PubMed
    Adam's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP